149 related articles for article (PubMed ID: 10603327)
1. Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus.
Volchkova VA; Klenk HD; Volchkov VE
Virology; 1999 Dec; 265(1):164-71. PubMed ID: 10603327
[TBL] [Abstract][Full Text] [Related]
2. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer.
Volchkova VA; Feldmann H; Klenk HD; Volchkov VE
Virology; 1998 Oct; 250(2):408-14. PubMed ID: 9792851
[TBL] [Abstract][Full Text] [Related]
3. Processing of the Ebola virus glycoprotein by the proprotein convertase furin.
Volchkov VE; Feldmann H; Volchkova VA; Klenk HD
Proc Natl Acad Sci U S A; 1998 May; 95(10):5762-7. PubMed ID: 9576958
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus.
Falzarano D; Krokhin O; Wahl-Jensen V; Seebach J; Wolf K; Schnittler HJ; Feldmann H
Chembiochem; 2006 Oct; 7(10):1605-11. PubMed ID: 16977667
[TBL] [Abstract][Full Text] [Related]
5. Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP.
Barrientos LG; Martin AM; Rollin PE; Sanchez A
Biochem Biophys Res Commun; 2004 Oct; 323(2):696-702. PubMed ID: 15369806
[TBL] [Abstract][Full Text] [Related]
6. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
[TBL] [Abstract][Full Text] [Related]
7. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
8. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA.
Löber C; Anheier B; Lindow S; Klenk HD; Feldmann H
Virology; 2001 Oct; 289(2):224-9. PubMed ID: 11689045
[TBL] [Abstract][Full Text] [Related]
9. Release of viral glycoproteins during Ebola virus infection.
Volchkov VE; Volchkova VA; Slenczka W; Klenk HD; Feldmann H
Virology; 1998 May; 245(1):110-9. PubMed ID: 9614872
[TBL] [Abstract][Full Text] [Related]
10. Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins.
Whitehead SS; Hruby DE
Virology; 1994 Apr; 200(1):154-61. PubMed ID: 8128619
[TBL] [Abstract][Full Text] [Related]
11. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
[TBL] [Abstract][Full Text] [Related]
12. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of Marburg virus glycoprotein.
Volchkov VE; Volchkova VA; Ströher U; Becker S; Dolnik O; Cieplik M; Garten W; Klenk HD; Feldmann H
Virology; 2000 Mar; 268(1):1-6. PubMed ID: 10683320
[TBL] [Abstract][Full Text] [Related]
14. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.
Ito H; Watanabe S; Takada A; Kawaoka Y
J Virol; 2001 Feb; 75(3):1576-80. PubMed ID: 11152533
[TBL] [Abstract][Full Text] [Related]
15. Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells.
Zhou P; Devadas K; Tewari D; Jegorow A; Notkins AL
J Immunol; 1999 Jul; 163(2):906-12. PubMed ID: 10395686
[TBL] [Abstract][Full Text] [Related]
16. Secreted glycoprotein from Live Zaire ebolavirus-infected cultures: preparation, structural and biophysical characterization, and thermodynamic stability.
Barrientos LG; Martin AM; Wohlhueter RM; Rollin PE
J Infect Dis; 2007 Nov; 196 Suppl 2():S220-31. PubMed ID: 17940953
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments.
Baghian A; Luftig M; Black JB; Meng YX; Pau CP; Voss T; Pellett PE; Kousoulas KG
Virology; 2000 Mar; 269(1):18-25. PubMed ID: 10725194
[TBL] [Abstract][Full Text] [Related]
18. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.
Sanchez A; Ksiazek TG; Rollin PE; Miranda ME; Trappier SG; Khan AS; Peters CJ; Nichol ST
J Infect Dis; 1999 Feb; 179 Suppl 1():S164-9. PubMed ID: 9988180
[TBL] [Abstract][Full Text] [Related]
19. A new Ebola virus nonstructural glycoprotein expressed through RNA editing.
Mehedi M; Falzarano D; Seebach J; Hu X; Carpenter MS; Schnittler HJ; Feldmann H
J Virol; 2011 Jun; 85(11):5406-14. PubMed ID: 21411529
[TBL] [Abstract][Full Text] [Related]
20. Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif.
Gallaher WR; Garry RF
Viruses; 2015 Jan; 7(1):285-305. PubMed ID: 25609303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]